Skip to main content

Arthroplasty, Knee Replacement

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

DyAnsys
DyAnsysCA - San Mateo
1 program
Primary ReliefN/A1 trial
Active Trials
NCT05416294Withdrawn0Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
DyAnsysPrimary Relief

Clinical Trials (1)

NCT05416294DyAnsysPrimary Relief

Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries

Start: Aug 2022Est. completion: Dec 20240
N/AWithdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.